Skip to main content
NVDA-2.58%AAPL+3.15%GOOGL+0.50%MSFT-0.13%AMZN-0.26%TSM-1.46%SPCX+0.70%AVGO-0.67%META-1.29%TSLA-0.60%SKHY-4.39%MU-4.61%BRK-B-0.24%LLY+0.04%JPM-0.72%WMT-0.10%AMD-3.24%V-0.17%XOM+0.85%ASMLa-1.66%JNJ-0.04%INTC-4.93%MA-0.53%0700.HK-1.94%1398.HK+0.79%ORCL-4.28%ABBV+1.09%BAC-0.57%CSCO-1.08%CVX-0.28%COST-0.14%KO+0.67%LRCX-5.12%CAT-1.58%AP2d-1.55%0005.HK-0.78%AMAT-2.74%UNH-0.99%HSBA.L-1.30%DELL-3.27%PG+0.48%MS-1.16%GE-0.76%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.19%HD-1.90%0939.HK+1.66%GS-1.28%NZDJPY-2.64%AUDJPY-1.85%CHFJPY-1.61%NZDCAD-1.47%EURNZD+1.44%NZDUSD-1.43%GBPNZD+1.39%GBPJPY-1.26%EURJPY-1.24%USDJPY-1.24%CADJPY-1.18%NZDCHF-1.07%USDZAR+1.02%USDNOK+0.90%USDSEK+0.90%EURZAR+0.84%AUDNZD+0.81%GBPZAR+0.76%EURNOK+0.72%EURSEK+0.71%AUDCAD-0.70%USDTHB+0.67%AUDDKK-0.65%AUDUSD-0.62%EURAUD+0.62%GBPAUD+0.58%CHFNOK+0.56%CHFSEK+0.56%AUDSGD-0.55%USDMXN+0.53%USDPLN+0.45%NZDSGD-0.43%GBPTRY+0.41%CADCHF+0.41%NOKJPY-0.39%USDCHF+0.39%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.28%EURPLN+0.26%AUDCHF-0.24%SGDJPY+0.23%NZDMXN-0.20%EURHKD-0.19%USDDKK+0.18%USDILS+0.16%USDTRY+0.11%USDCNH+0.10%EURSGD+0.09%GBPCAD-0.09%AUDNOK+0.07%EURCNH-0.06%EURCAD-0.06%CHFSGD-0.06%PLNJPY+0.06%EURCZK-0.05%USDCOP-0.04%EURGBP+0.04%USDCAD-0.04%GBPUSD-0.03%USDHKD+0.02%EURUSD-0.01%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.16%GAGUSD-5.41%XAGUSD-5.41%UKOIL+5.19%USOIL+5.04%HG1-4.88%XAUUSD-1.85%GAUUSD-1.85%XNGUSD+1.63%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.43%ETHUSD-0.13%USDTUSD-0.02%XRPUSD-3.04%SOLUSD-1.72%TRXUSDT+0.18%ZECUSDT-9.00%DOGEUSD-2.63%XMRUSDT+0.93%LINKUSD-1.35%XLMUSD-1.44%BCHUSDT-9.83%LTCUSD-1.66%UNIUSD-1.56%TONUSD+24.88%HBARUSDT-2.45%SUIUSD-4.15%TAOUSDT-5.36%AAVEUSD-2.39%DOTUSDT-1.74%ICPUSDT-0.94%ONDOUSDT-3.15%WLDUSDT-2.91%ATOMUSDT-2.92%ARBUSDT-0.91%JUPUSDT-3.39%INJUSDT-2.24%STXUSDT-4.53%FETUSDT-2.86%TIAUSDT-0.87%PYTHUSDT-1.42%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.45%WIFUSDT-5.38%OPUSDT-3.00%POLUSDT-4.46%IOTAUSDT-3.74%AXSUSDT-2.47%FARTCOINUSDT-2.90%EOSUSDT-2.66%DYDXUSDT-1.99%ORDIUSDT-0.80%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.58%AAPL+3.15%GOOGL+0.50%MSFT-0.13%AMZN-0.26%TSM-1.46%SPCX+0.70%AVGO-0.67%META-1.29%TSLA-0.60%SKHY-4.39%MU-4.61%BRK-B-0.24%LLY+0.04%JPM-0.72%WMT-0.10%AMD-3.24%V-0.17%XOM+0.85%ASMLa-1.66%JNJ-0.04%INTC-4.93%MA-0.53%0700.HK-1.94%1398.HK+0.79%ORCL-4.28%ABBV+1.09%BAC-0.57%CSCO-1.08%CVX-0.28%COST-0.14%KO+0.67%LRCX-5.12%CAT-1.58%AP2d-1.55%0005.HK-0.78%AMAT-2.74%UNH-0.99%HSBA.L-1.30%DELL-3.27%PG+0.48%MS-1.16%GE-0.76%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.19%HD-1.90%0939.HK+1.66%GS-1.28%NZDJPY-2.64%AUDJPY-1.85%CHFJPY-1.61%NZDCAD-1.47%EURNZD+1.44%NZDUSD-1.43%GBPNZD+1.39%GBPJPY-1.26%EURJPY-1.24%USDJPY-1.24%CADJPY-1.18%NZDCHF-1.07%USDZAR+1.02%USDNOK+0.90%USDSEK+0.90%EURZAR+0.84%AUDNZD+0.81%GBPZAR+0.76%EURNOK+0.72%EURSEK+0.71%AUDCAD-0.70%USDTHB+0.67%AUDDKK-0.65%AUDUSD-0.62%EURAUD+0.62%GBPAUD+0.58%CHFNOK+0.56%CHFSEK+0.56%AUDSGD-0.55%USDMXN+0.53%USDPLN+0.45%NZDSGD-0.43%GBPTRY+0.41%CADCHF+0.41%NOKJPY-0.39%USDCHF+0.39%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.28%EURPLN+0.26%AUDCHF-0.24%SGDJPY+0.23%NZDMXN-0.20%EURHKD-0.19%USDDKK+0.18%USDILS+0.16%USDTRY+0.11%USDCNH+0.10%EURSGD+0.09%GBPCAD-0.09%AUDNOK+0.07%EURCNH-0.06%EURCAD-0.06%CHFSGD-0.06%PLNJPY+0.06%EURCZK-0.05%USDCOP-0.04%EURGBP+0.04%USDCAD-0.04%GBPUSD-0.03%USDHKD+0.02%EURUSD-0.01%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.16%GAGUSD-5.41%XAGUSD-5.41%UKOIL+5.19%USOIL+5.04%HG1-4.88%XAUUSD-1.85%GAUUSD-1.85%XNGUSD+1.63%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.43%ETHUSD-0.13%USDTUSD-0.02%XRPUSD-3.04%SOLUSD-1.72%TRXUSDT+0.18%ZECUSDT-9.00%DOGEUSD-2.63%XMRUSDT+0.93%LINKUSD-1.35%XLMUSD-1.44%BCHUSDT-9.83%LTCUSD-1.66%UNIUSD-1.56%TONUSD+24.88%HBARUSDT-2.45%SUIUSD-4.15%TAOUSDT-5.36%AAVEUSD-2.39%DOTUSDT-1.74%ICPUSDT-0.94%ONDOUSDT-3.15%WLDUSDT-2.91%ATOMUSDT-2.92%ARBUSDT-0.91%JUPUSDT-3.39%INJUSDT-2.24%STXUSDT-4.53%FETUSDT-2.86%TIAUSDT-0.87%PYTHUSDT-1.42%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.45%WIFUSDT-5.38%OPUSDT-3.00%POLUSDT-4.46%IOTAUSDT-3.74%AXSUSDT-2.47%FARTCOINUSDT-2.90%EOSUSDT-2.66%DYDXUSDT-1.99%ORDIUSDT-0.80%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
LI

LivaNova PLC (LIVN)

NASDAQ • Healthcare

$78.93
-$1.76 (-2.2%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$80.22
Previous Close$78.93
Day Range$78.11 - $80.37
Avg. Volume (3M)597.8K
Market Cap$4.2B
P/E Ratio22.9
52 Week Range
$48.82$85.76
Next EarningsIn 55 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$390.6M100%
Gross Profitminus cost of goods$273.7M70%
Operating Incomeminus R&D and overhead$49.5M13%
Net Incomeminus taxes and the rest$108.6M28%

In plain terms: out of every $100 in revenue, LivaNova PLC keeps $28 as net profit.

Fundamentals & Financials

Revenue (TTM)
$1.4B
Net Income (TTM)
$188.5M
EPS (TTM)
$3.45
ROA (TTM)
7.14%
Current Ratio
1.45
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+7.5%Q1 2026$0.86
+15.3%Q2 2026$0.98
+15.6%Q3 2026$1.26
Next

Nov 4

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +15.6%

LivaNova topped expectations on both the top and bottom line in the second fiscal quarter of 2026, reported August 5, 2026, as revenue of $390.6 million topped the $380.5 million estimate (+2.7%, verdict: topped) and adjusted EPS of $1.26 topped the $1.09 estimate (+15.6%, verdict: topped). Revenue rose 10.8% to about $390.6 million from roughly $352.5 million a year ago, reflecting results across its cardiopulmonary care, neuromodulation, and temporary life support device businesses. Profitability stayed elevated, with gross margin near 70% and operating margin around 13%, alongside operating income of about $49.5 million. The company generated operating cash flow of roughly $66.6 million in the quarter. For the next period, consensus calls for EPS of $1.04 on revenue of $381.1 million.

View full earnings history

About LivaNova PLC

LivaNova PLC designs and sells medical technology for cardiopulmonary care, neuromodulation, and temporary life support, with $1.4 billion in FY2025 revenue. Listed on NASDAQ as LIVN, the company operates in the healthcare sector through device businesses used in heart-lung procedures, vagus nerve stimulation, and acute circulatory or respiratory support.

Name
LivaNova PLC
CEO
Vladimir A. Makatsaria
Website
www.livanova.com
Industry
Healthcare
Year Founded
1987
Employees
3,300

Today's Snapshot

AI-generated

So far today, LIVN is trading 1.1% lower at 78.09, while its sector was flat.

Trading Volume

Below 10d avg (528.9K)

87.2K

vs S&P 500 Today

Underperforming Market

-0.51%

Updated: September 10, 2026 at 16:43 UTC

Technical Indicators

2 Buy2 Neutral4 Sell
LIVN is tilted toward sell as short-term moving averages and momentum indicators show pressure, while trend strength is weak. The stock is trading below its 10- and 20-day averages but remains above longer-term 100/200-day levels, suggesting longer-term support even as recent readings—CCI and momentum—are negative. ADX denotes a lack of a strong trend, volatility is moderate, and on-balance volume shows buying interest that partially offsets price weakness. The pivot sits above the market, reinforcing near-term resistance. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$70.20 - $80.06
    Sell
  • RSI (14)43.49
    Neutral
  • Stochastic %K (14, 3, 3)31.48
    Neutral
  • MACD Level (12, 26)-0.01
    Sell

Peers & Related Assets

SRRKScholar Rock Holding Corporation
$54.62-4.9%
HTFLHeartflow, Inc. Common Stock
$46.67-2.3%
IDYAIDEAYA Biosciences, Inc.
$38.35-1.3%
IRONDisc Medicine, Inc.
$76.51-0.4%
PBHPrestige Consumer Healthcare Inc.
$48.7-2.2%
SGRYSurgery Partners, Inc.
$14.12+1.1%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.